Literature DB >> 24768813

Coffee: a panacea or snake oil for the liver?

Radhika Kumari1, W Ray Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24768813      PMCID： PMC4142094          DOI： 10.1016/j.cgh.2014.04.015

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  16 in total

1.  Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

Authors:  Francesca Bravi; Cristina Bosetti; Alessandra Tavani; Vincenzo Bagnardi; Silvano Gallus; Eva Negri; Silvia Franceschi; Carlo La Vecchia
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

2.  Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

3.  Unexpected effects of coffee consumption on liver enzymes.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

4.  Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study.

Authors:  Umberto Gelatti; Loredana Covolo; Michela Franceschini; Francesco Pirali; Alessandro Tagger; Maria Lisa Ribero; Paola Trevisi; Claudia Martelli; Giuseppe Nardi; Francesco Donato
Journal:  J Hepatol       Date:  2005-04       Impact factor: 25.083

5.  Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.

Authors:  Ina Marie Andersen; Guro Tengesdal; Benedicte Alexandra Lie; Kirsten Muri Boberg; Tom Hemming Karlsen; Johannes Roksund Hov
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-25       Impact factor: 11.382

6.  Association of caffeine intake and histological features of chronic hepatitis C.

Authors:  Charlotte E Costentin; Françoise Roudot-Thoraval; Elie-Serge Zafrani; Fatiha Medkour; Jean-Michel Pawlotsky; Ariane Mallat; Christophe Hézode
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

7.  Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.

Authors:  R Urgert; S Meyboom; M Kuilman; H Rexwinkel; M N Vissers; M Klerk; M B Katan
Journal:  BMJ       Date:  1996-11-30

8.  Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways.

Authors:  Olav A Gressner; Birgit Lahme; Katharina Rehbein; Monika Siluschek; Ralf Weiskirchen; Axel M Gressner
Journal:  J Hepatol       Date:  2008-04-30       Impact factor: 25.083

9.  Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Authors:  Neal D Freedman; James E Everhart; Karen L Lindsay; Marc G Ghany; Teresa M Curto; Mitchell L Shiffman; William M Lee; Anna S Lok; Adrian M Di Bisceglie; Herbert L Bonkovsky; John C Hoefs; Jules L Dienstag; Chihiro Morishima; Christian C Abnet; Rashmi Sinha
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

10.  The relationship of coffee consumption with mortality.

Authors:  Esther Lopez-Garcia; Rob M van Dam; Tricia Y Li; Fernando Rodriguez-Artalejo; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.